Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice

M Breuer1, R Slebos, S Verbeek

  • 1Division of Molecular Genetics, the Netherlands Cancer Institute, Amsterdam.

Nature
|July 6, 1989
PubMed

Insights

Moloney murine leukaemia virus (MuLV) and N-ethyl-N-nitrosourea (ENU) accelerate T-cell lymphoma development in pim-1 transgenic mice. These findings suggest pim-1 and c-myc oncogenes synergize in lymphoma induction.

Area of Science:

  • Oncology
  • Virology
  • Genetics

Background:

  • Moloney murine leukaemia virus (MuLV) infection causes T-cell lymphomas in mice with a long latency period.
  • The pim-1 oncogene is often found near MuLV DNA integrations in these lymphomas.
  • Transgenic mice overexpressing pim-1 are predisposed to T-cell lymphomas, but viral infection significantly shortens latency.

Purpose of the Study:

  • To investigate the synergistic role of pim-1 and myc oncogenes in lymphomagenesis.
  • To evaluate the utility of pim-1 transgenic mice for assessing chemical carcinogen oncogenic potential.

Main Methods:

  • Infection of pim-1 transgenic and non-transgenic mice with MuLV.
  • Administration of a single low dose of the chemical carcinogen N-ethyl-N-nitrosourea (ENU) to pim-1 transgenic and non-transgenic mice.
  • Analysis of lymphoma development, latency periods, and oncogene expression (pim-1, c-myc, N-myc) in induced tumors.

Main Results:

  • MuLV infection in pim-1 transgenic mice led to rapid T-cell lymphoma development in all mice, with MuLV DNA integrating near c-myc or N-myc.
  • ENU exposure induced T-cell lymphomas in nearly all pim-1 transgenic mice, compared to only 15% of non-transgenic controls, within 200 days.
  • All induced lymphomas, regardless of genotype or induction method, showed high c-myc messenger RNA levels, supporting pim-1 and c-myc synergy.

Conclusions:

  • The pim-1 oncogene synergizes with c-myc in the induction of T-cell lymphomas.
  • Pim-1 transgenic mice serve as a sensitive model for evaluating the oncogenic potential of chemical compounds.
  • This model system advances our understanding of lymphomagenesis and offers a platform for carcinogenicity testing.